← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vulcan Biologics, Inc.
Irvine, CA
$1,802,324
Total funding
4
Grants
Funding over time
peak $1M · FY2020–24$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NSF$1,234,854 · 2
NIH$567,470 · 2
By mechanism
—$1,234,854 · 2
N43$299,914 · 1
R43$267,556 · 1
Investigators at Vulcan Biologics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
SBIR Phase II: Bacteriophage-Based Microbial Gene Therapy Platform for In Situ Engineering of Microbiomes$989,854
· FY2021 · TIP
SBIR Topic 131: Development of Bacteriophage for Treatment of Mycobacterial Infections$299,914
N43 · FY2024 · AI
Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy$256,580
R43 · FY2020 · DE
SBIR Phase I: Bacteriophage-Based Microbial Gene Therapy Platform for In Situ Engineering of Microbiomes$245,000
· FY2020 · TIP
Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy$10,976
R43 · FY2021 · DE